Kluyvera infections in the pediatric population

J. Elliot Carter; Javier A. Laurini; Kelly N. Mizell

doi:10.1097/INF.0b013e318170af5b

Kluyvera infections in the pediatric population

J. Elliot Carter, Javier A. Laurini, Kelly N. Mizell

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

In pediatric patients, Kluyvera spp. has emerged as a cause of disease ranging from soft tissue infections to sepsis with multiorgan failure. Successful treatment options include third-generation cephalosporins, tetracycline, aminoglycosides, and fluoroquinolones, but resistance to first- and second-generation cephalosporins persists. Clinicians should be aware of the spectrum of disease and increasing clinical importance associated with this emerging pathogen.

Original language	English (US)
Pages (from-to)	839-841
Number of pages	3
Journal	Pediatric Infectious Disease Journal
Volume	27
Issue number	9
DOIs	https://doi.org/10.1097/INF.0b013e318170af5b
State	Published - Sep 2008
Externally published	Yes

Keywords

Infection
Kluyvera
Pediatric

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Microbiology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/INF.0b013e318170af5b

Cite this

@article{d29a40f39b1042e29d028eda2f568ce5,

title = "Kluyvera infections in the pediatric population",

abstract = "In pediatric patients, Kluyvera spp. has emerged as a cause of disease ranging from soft tissue infections to sepsis with multiorgan failure. Successful treatment options include third-generation cephalosporins, tetracycline, aminoglycosides, and fluoroquinolones, but resistance to first- and second-generation cephalosporins persists. Clinicians should be aware of the spectrum of disease and increasing clinical importance associated with this emerging pathogen.",

keywords = "Infection, Kluyvera, Pediatric",

author = "Carter, {J. Elliot} and Laurini, {Javier A.} and Mizell, {Kelly N.}",

year = "2008",

month = sep,

doi = "10.1097/INF.0b013e318170af5b",

language = "English (US)",

volume = "27",

pages = "839--841",

journal = "Pediatric Infectious Disease Journal",

issn = "0891-3668",

publisher = "Lippincott Williams and Wilkins",

number = "9",

}

TY - JOUR

T1 - Kluyvera infections in the pediatric population

AU - Carter, J. Elliot

AU - Laurini, Javier A.

AU - Mizell, Kelly N.

PY - 2008/9

Y1 - 2008/9

N2 - In pediatric patients, Kluyvera spp. has emerged as a cause of disease ranging from soft tissue infections to sepsis with multiorgan failure. Successful treatment options include third-generation cephalosporins, tetracycline, aminoglycosides, and fluoroquinolones, but resistance to first- and second-generation cephalosporins persists. Clinicians should be aware of the spectrum of disease and increasing clinical importance associated with this emerging pathogen.

AB - In pediatric patients, Kluyvera spp. has emerged as a cause of disease ranging from soft tissue infections to sepsis with multiorgan failure. Successful treatment options include third-generation cephalosporins, tetracycline, aminoglycosides, and fluoroquinolones, but resistance to first- and second-generation cephalosporins persists. Clinicians should be aware of the spectrum of disease and increasing clinical importance associated with this emerging pathogen.

KW - Infection

KW - Kluyvera

KW - Pediatric

UR - http://www.scopus.com/inward/record.url?scp=53049105598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53049105598&partnerID=8YFLogxK

U2 - 10.1097/INF.0b013e318170af5b

DO - 10.1097/INF.0b013e318170af5b

M3 - Article

C2 - 18645547

AN - SCOPUS:53049105598

SN - 0891-3668

VL - 27

SP - 839

EP - 841

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

IS - 9

ER -

Kluyvera infections in the pediatric population

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this